Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
Efficacy of doxorubicin (DOX) in colorectal cancer treatment is limited by undesirable side-effects, which are partially due to nonspecific delivery DOX to the tumor target site. This study aimed to develop pH-responsive dextrin nanogels (DNGs) as anticancer drug carriers with pH-controlled drug rel...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Elsevier Ltd
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/21037 |